Add Yahoo as a preferred source to see more of our stories on Google. Scientists in Newcastle, where the test was developed, hailed it as a "revolution" [BBC] A pioneering test is improving early ...

Four years ago, Nida Allam came up short in her quest for an open seat in the heart of North Carolina’s Research Triangle. Now she’s back for a rematch with Rep. Valerie P. Foushee — and the ...

A closely watched clinical trial in Britain that screened blood for early detection of cancer did not show a reduction in diagnoses at later stages of the disease. By Rebecca Robbins and Gina Kolata A ...

The Texas Longhorns opened their 2026 season with eight straight wins and a pitching staff entirely worthy of national praise. But the sample size was small and the level of competition left several ...

There's been new research into using blood tests to detect early-stage cancer. Tourists watch killer whale show turn to tragedy The three costly purchases that retirees say they regret Australia’s ...

A team of researchers from Taiwan has developed PanMETAI, an AI-powered platform that analyzes metabolic fingerprints in a simple blood sample to detect pancreatic cancer at its earliest stages—when ...

The House narrowly rejected a war powers resolution that would halt President Donald Trump’s attack on Iran. The Senate defeated a similar measure on Wednesday. The Democrats who voted against the War ...

On the Monday, March 2, 2026, episode of The Excerpt podcast: Primary season is officially underway, and even though President Donald Trump isn’t on the ballot, his influence is shaping races across ...

A large, three-year clinical trial designed to demonstrate how Grail’s blood test for early cancer detection could work in a broad population has preliminary results showing reduction in late-stage ...

It won't take long for everyone to know whether or not Michigan football is legitimate in 2026 or not. The answer to that question will come as early as Week 2, when the Wolverines host Oklahoma at ...

Proprietary multianalyte and multiomic assay with optimized machine learning capabilities achieve significantly higher 82% sensitivity and 97% specificity in high-risk populations ClearNote Health, a ...